|1.||Choi, Jun Shik: 2 articles (06/2003 - 08/2002)|
|2.||Pieniazek, W: 2 articles (01/2001 - 01/2001)|
|3.||Taylor, Frederick R: 1 article (09/2013)|
|4.||Ramakrishnan, Rema: 1 article (09/2013)|
|5.||Kane, Robert L: 1 article (09/2013)|
|6.||Shamliyan, Tatyana A: 1 article (09/2013)|
|7.||Miller, Jennifer Biggs: 1 article (09/2013)|
|8.||Wang, Shi-Yi: 1 article (09/2013)|
|9.||Choi, Jae-Young: 1 article (09/2013)|
|10.||Tyczka, Joanna: 1 article (06/2013)|
|1.||Hypertension (High Blood Pressure)
01/01/1985 - "Beta-blockade by acebutolol was highly effective in treating mild-moderate arterial hypertension in the elderly."
10/01/1981 - "In mild hypertension good results increased from 75% after acebutolol only to 100% after this combination. "
10/06/1983 - "It can therefore be concluded that acebutolol is a beta-adrenolytic drug which is reliably effective in the treatment of essential arterial hypertension, well tolerated and easily administered."
01/01/1983 - "The results of this pilot study suggest that acebutolol warrants further investigation as an effective and well-tolerated treatment of hypertension in pregnancy."
01/01/2002 - "With regard to the results of our clinical study we can consider acebutolol to be effective and safe antihypertensive drug in the treatment of hypertension in pregnancy."
|2.||Cardiac Arrhythmias (Arrythmia)
05/01/1985 - "The antiarrhythmic activity of acebutolol, its ancillary pharmacologic properties, and its tolerance by a diverse group of patients make acebutolol a significant tool for the clinician in the management of chronic arrhythmia."
01/01/1975 - "It was concluded that acebutolol is a cardioselective beta-blocker which by intravenous route may be useful in the treatment of selected cardiac arrhythmias."
11/01/1984 - "[Efficacy of acebutolol in hypertensive and arrhythmia patients]."
04/01/1991 - "Chronic use of acebutolol in the treatment of cardiac arrhythmias."
02/01/1983 - "Suppression of ventricular arrhythmia by acebutolol."
03/01/1997 - "The APSI trial was a randomized placebo-controlled trial designed to assess the efficacy of 1 year of treatment by acebutolol in high-risk patients who had survived an acute myocardial infarction. "
09/25/1990 - "Efficacy of acebutolol after acute myocardial infarction (the APSI trial). "
09/25/1990 - "A randomized, placebo-controlled trial was carried out to determine the effectiveness of acebutolol in preventing late death in high-risk patients surviving an acute myocardial infarction (MI). "
08/01/1990 - "Acebutolol et Prévention Secondaire de l'Infarctus (APSI), a randomized, placebo-controlled trial, was designed to test long-term acebutolol, 200 mg twice daily, a beta blocker with mild intrinsic sympathomimetic activity, in the prevention of late death in high-risk postacute myocardial infarction (AMI) patients. "
09/01/1985 - "The hemodynamic dose-response effects of intravenous (25 and 50 mg) and oral (200 and 400 mg) acebutolol were compared in a randomized between-group study in men within 17 hours of an acute uncomplicated myocardial infarction. "
|4.||Ventricular Premature Complexes (Premature Ventricular Contraction)
03/01/1986 - "Oral acebutolol is also effective in suppressing premature ventricular contractions, and in small numbers of patients generally beneficial results were obtained in supraventricular and ventricular arrhythmias with intravenous administration. "
05/01/1985 - "The safety and efficacy of oral acebutolol therapy for the suppression of premature ventricular contractions (PVCs) were assessed in two clinical trials pooled for analysis. "
05/01/1985 - "Acebutolol for premature ventricular contractions: short- and long-term effects."
01/01/1984 - "[Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. "
05/01/1983 - "Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study."
|5.||Coronary Artery Disease (Coronary Atherosclerosis)
09/01/1987 - "Systemic and coronary hemodynamic effects of acebutolol (10 mg i.v.), a cardioselective beta-adrenoceptor blocking agent were investigated in 11 patients with coronary artery disease and significant arterial obstructive lesions. "
05/01/1985 - "In 11 patients (10 men, one woman) with coronary artery disease, acebutolol at 1 mg/kg infused over 15 minutes decreased heart rate and slowed conduction, increased the refractoriness of the atrioventricular node without a significant change in the atrial refractoriness, and at plasma levels greater than or equal to 1000 ng/ml slowed His-Purkinje conduction. "
07/01/1984 - "The hemodynamic dose-response effects of intravenous acebutolol, a cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, were evaluated in 12 male subjects with angiographically confirmed coronary artery disease. "
07/01/1982 - "Acebutolol, a relatively cardioselective beta-adrenergic blocking drug, was administered to 20 men with coronary artery disease and angina. "
07/01/1982 - "Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease."
|5.||Pindolol (LB 46)
|6.||Calcium Channels (Calcium Channel)
|1.||Drug Therapy (Chemotherapy)